NRL and retinitis pigmentosa 1: Yu et al. (21) attempted to knockdown the Nrl gene to prevent retinal degeneration in a mouse model and suggested an adeno-associated virus (AAV)-based CRISPR-Cas9 system for gene disruption as a promising treatment option for patients with RP.